029770980	029770980	CD	B-NP	O
|	|	NNP	I-NP	B-cell_type
NEBMC	NEBMC	NNP	I-NP	I-cell_type
|	|	VBD	B-VP	O
05930410	05930410	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
237605	237605	CD	B-NP	O
|	|	CC	I-NP	O
11/14/1994	11/14/1994	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/1994	10/12/1994	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/17/1994	10/17/1994	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
RULE	RULE	NN	B-NP	O
OUT	OUT	NN	I-NP	O
MYOCARDIAL	MYOCARDIAL	NN	I-NP	O
INFARCT	INFARCT	NN	I-NP	O
.	.	.	O	O

CONTRIBUTING	CONTRIBUTING	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
HYPERTENSION	HYPERTENSION	NN	B-NP	O
,	,	,	O	O
CORONARY	CORONARY	NNP	B-NP	O
ARTERY	ARTERY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
DIABETES	DIABETES	NNP	B-NP	O
,	,	,	O	O
SCHIZOPHRENIA	SCHIZOPHRENIA	NNP	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
67	67	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
black	black	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
SVT	SVT	NN	B-NP	O
and	and	CC	I-NP	O
schizophrenia	schizophrenia	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
45	45	CD	B-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
burning	burning	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
began	begin	VBD	B-VP	O
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
first	first	JJ	I-NP	O
rule	rule	NN	I-NP	O
out	out	RP	B-ADVP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
workup	workup	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
ETT	ETT	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
40	40	CD	B-NP	O
seconds	second	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
71	71	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
138/68	138/68	CD	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
images	image	NNS	I-NP	O
:	:	:	O	O
anteroapical	anteroapical	JJ	B-NP	O
defect	defect	NN	I-NP	O
on	on	IN	B-PP	O
stress	stress	NN	B-NP	O
images	image	NNS	I-NP	O
with	with	IN	B-PP	O
reperfusion	reperfusion	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
rate	rate	NN	B-NP	O
related	related	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
SVTs	SVT	NNS	B-NP	B-protein
or	or	CC	O	O
other	other	JJ	B-NP	O
precipitants	precipitant	NNS	I-NP	O
that	that	WDT	B-NP	O
increase	increase	VBP	B-VP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
since	since	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
experiences	experience	VBZ	B-VP	O
no	no	DT	B-NP	O
chest	ch	JJS	I-NP	O
discomfort	discomfort	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NNP	B-NP	O
75mg	75mg	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
today	today	NN	I-NP	O
complaining	complaining	NN	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
burning	burning	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
1	1	CD	I-NP	O
time	time	NN	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
which	which	WDT	B-NP	O
awakened	awaken	VBD	B-VP	O
her	her	PRP	B-NP	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
Mylanta	Mylanta	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
a	a	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
burning	burn	VBG	B-VP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
while	while	IN	B-SBAR	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
eaten	eat	VBN	I-VP	O
1	1	CD	B-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
Mylanta	Mylanta	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ambulance	ambulance	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
and	and	CC	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
above	above	IN	B-PP	O
:	:	:	O	O
Adult	Adult	JJ	B-NP	O
onset	onset	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
ingrown	ingrown	NN	I-NP	O
toe	toe	NN	I-NP	O
nail	nail	NN	I-NP	O
,	,	,	O	O
diverticulosis	diverticulosis	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
nose	nose	NN	I-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
right	right	JJ	I-NP	O
pinna	pinna	NN	I-NP	O
ear	ear	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
schizophrenia	schizophrenia	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
colonic	colonic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
with	with	IN	B-PP	O
guaiac	guaiac	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stools	stool	NNS	I-NP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
barium	barium	NN	I-NP	O
enema	enema	NN	I-NP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
year	year	NN	I-NP	O
demonstrating	demonstrate	VBG	B-VP	O
colonic	colonic	JJ	B-NP	O
diverticula	diverticula	NN	I-NP	O
,	,	,	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Medications	Medication	NNS	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
Verapamil	Verapamil	NN	B-NP	O
SR	SR	NN	I-NP	O
240mg	240mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Naprosyn	Naprosyn	NNP	B-NP	O
375mg	375mg	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
,	,	,	O	O
fluphenazine	fluphenazine	NN	B-NP	B-protein
35cc	35cc	NN	I-NP	I-protein
IM	IM	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
Ibuprofen	Ibuprofen	NNP	B-NP	O
400mg	400mg	NNP	I-NP	O
p.o.	p.o.	NNP	I-NP	O
t.i.d.	t.i.d.	NNP	I-NP	O
,	,	,	O	O
Nitropatch	Nitropatch	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
75mg	75mg	CD	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
45	45	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
20mg	20mg	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Librium	Librium	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

Family	Family	RB	B-NP	O
history	history	NN	I-NP	O
includes	include	VBZ	B-VP	O
a	a	DT	B-NP	O
brother	brother	NN	I-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sister	sister	NN	I-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
at	at	IN	B-PP	O
71	71	CD	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

Social	Social	NNP	B-NP	O
History	History	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
widow	widow	NN	I-NP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
grandson	grandson	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	O
factory	factory	NN	I-NP	O
seamstress	seamstress	NN	I-NP	O
who	who	WP	B-NP	O
stopped	stop	VBD	B-VP	O
smoking	smoke	VBG	I-VP	O
25	25	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
smoked	smoke	VBN	I-VP	O
a	a	DT	B-NP	O
1/2	1/2	CD	I-NP	O
pack	pack	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
usage	usage	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	JJ	I-NP	O
black	black	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98.2	98.2	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/80	140/80	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
at	at	IN	B-PP	O
16	16	CD	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
,	,	,	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
:	:	:	O	O
Heart	Heart	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
and	and	CC	I-NP	O
non-tender	non-tender	JJ	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hyperpigmented	hyperpigmented	JJ	I-NP	O
patch	patch	NN	I-NP	O
centrally	centrally	RB	B-ADVP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Extremities	Extremity	NNS	B-NP	O
are	be	VBP	B-VP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
or	or	CC	O	O
joint	joint	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
left	left	JJ	I-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
had	have	VBD	B-VP	O
hypertrophic	hypertrophic	JJ	B-NP	O
toe	toe	NN	I-NP	O
nails	nail	NNS	I-NP	O
,	,	,	O	O
tender	tender	NN	B-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ingrown	ingrown	JJ	I-NP	O
toenail	toenail	NN	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
was	be	VBD	B-VP	O
with	with	IN	B-PP	O
guaiac	guaiac	JJ	B-NP	O
positive	positive	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Neuro	Neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
non-focal	non-focal	JJ	I-ADJP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Admission	Admission	NN	B-NP	O
data	datum	NNS	I-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
144	144	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
107	107	CD	B-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
of	of	IN	B-PP	O
27	27	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.1	1.1	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
155	155	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
was	be	VBD	B-VP	O
430	430	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
and	and	CC	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
aside	aside	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
chronically	chronically	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
CKs	CK	NNS	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
8.7	8.7	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MCV	MCV	NN	I-NP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
and	and	CC	I-NP	O
93	93	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
13	13	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
95	95	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
intervals	interval	NNS	B-NP	O
of	of	IN	B-PP	O
.18	.18	CD	B-NP	O
,	,	,	I-NP	O
.81	.81	CD	I-NP	O
,	,	,	I-NP	O
.35	.35	CD	I-NP	O
and	and	CC	O	O
axis	axis	NN	B-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
with	with	IN	B-PP	O
Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
,	,	,	O	O
V2	V2	NN	B-NP	B-protein
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
flattening	flatten	VBG	B-VP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
infiltrates	infiltrate	NNS	B-NP	O
or	or	CC	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
system	system	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
CKs	CK	NNS	B-NP	B-protein
of	of	IN	B-PP	O
430	430	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
1.544	1.544	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
and	and	CC	I-NP	O
404	404	CD	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
.8	.8	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
75mg	75mg	CD	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
results	result	NNS	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
LAD	LAD	NN	I-NP	O
without	without	IN	B-PP	O
critical	critical	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
OMB1	OMB1	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	I-NP	O
OMB2	OMB2	NN	I-NP	B-protein
with	with	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
serial	serial	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
RCA	RCA	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
distal	distal	JJ	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
offered	offer	VBN	I-VP	O
PTCA	PTCA	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
critical	critical	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
declined	decline	VBD	B-VP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
would	would	MD	B-VP	O
send	send	VB	I-VP	O
her	her	PRP	B-NP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
dosage	dosage	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
and	and	CC	O	O
monitor	monitor	VB	B-VP	O
her	her	PRP$	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	O	O
perhaps	perhaps	RB	B-VP	O
re-offer	re-offer	VB	I-VP	O
her	her	PRP$	B-NP	O
PTCA	PTCA	NN	I-NP	B-protein
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
toe	toe	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
podiatry	podiatry	NN	B-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
ingrown	ingrown	JJ	I-NP	O
toenail	toenail	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
via	via	IN	B-PP	O
avulsion	avulsion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nail	nail	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
4	4	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Cephradine	Cephradine	NN	B-NP	O
500mg	500mg	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
all	all	DT	B-NP	O
Ansaid	Ansaid	NNP	I-NP	O
held	hold	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
guaiac	guaiac	JJ	I-NP	O
positive	positive	JJ	I-NP	O
stool	stool	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
monitored	monitor	VBN	B-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
GI	GI	NN	I-NP	O
workup	workup	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
anemia	anemia	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
studies	study	NNS	I-NP	O
performed	perform	VBN	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
detected	detect	VBD	B-VP	O
an	an	DT	B-NP	O
iron	iron	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
iron	iron	NN	I-NP	O
binding	binding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
246	246	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
B12	B12	NN	I-NP	B-protein
of	of	IN	B-PP	O
904	904	CD	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
of	of	IN	B-PP	O
10.4	10.4	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
ferritin	ferritin	NN	I-NP	B-protein
of	of	IN	B-PP	O
235	235	CD	B-NP	O
;	;	:	O	O
all	all	DT	B-NP	O
not	not	RB	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
perhaps	perhaps	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
Pepcid	Pepcid	NNP	B-NP	O
or	or	CC	I-NP	O
Ansaid	Ansaid	NNP	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
platelet	platelet	NN	I-NP	O
level	level	NN	I-NP	O
remained	remain	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
100	100	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
so	so	RB	B-ADVP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP	B-NP	O
normal	normal	JJ	I-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
schizophrenia	schizophrenia	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medicines	medicine	NNS	I-NP	O
:	:	:	O	O
MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325mg	325mg	CD	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Librium	Librium	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
42	42	CD	B-NP	O
units	unit	NNS	I-NP	O
sub	sub	NN	I-NP	O
q	q	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
100mg	100mg	CD	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
SR	SR	NN	I-NP	O
240mg	240mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q	q	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
Prolixin	Prolixin	NNP	B-NP	O
Decanoate	Decanoate	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
IM	IM	NN	I-NP	O
q	q	NN	I-NP	O
o	o	NN	I-NP	O
weekly	weekly	RB	B-ADVP	O
and	and	CC	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
1	1	CD	I-NP	I-protein
tablet	tablet	NN	I-NP	I-protein
sublingual	sublingual	JJ	I-NP	I-protein
q	q	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
home	home	NN	B-NP	O
health	health	NN	I-NP	O
aid	aid	NN	I-NP	O
and	and	CC	O	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
more	more	JJR	B-NP	O
compliance	compliance	NN	I-NP	O
with	with	IN	B-PP	O
medication	medication	NN	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
finger	finger	NN	B-NP	O
stick	stick	NN	I-NP	O
glucose	glucose	NN	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
administer	administer	VB	I-VP	O
her	her	PRP$	B-NP	O
Prolixin	Prolixin	NN	I-NP	B-protein
every	every	DT	B-NP	I-protein
week	week	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
800	800	CD	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CO	CO	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ED	ED	NNP	B-NP	O
GOMMER	GOMMER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EV87	EV87	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NATHAN	NATHAN	NNP	B-NP	O
BOFFA	BOFFA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
NU1	NU1	NNP	I-NP	O
BL782/5970	BL782/5970	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
5821	5821	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

M1COME1MJF	M1COME1MJF	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
11/25/94	11/25/94	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/5/94	6/5/94	CD	B-NP	O

